• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

奥地利门静脉高压管理和治疗共识指南（Billroth III）。

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

机构信息

Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

出版信息

Wien Klin Wochenschr. 2017 Nov;129(Suppl 3):135-158. doi: 10.1007/s00508-017-1262-3. Epub 2017 Oct 23.

DOI:10.1007/s00508-017-1262-3
PMID:29063233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5674135/
Abstract

The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.

摘要

比尔罗特 III 指南是在 2017 年 2 月 18 日于维也纳举行的奥地利胃肠病学和肝脏病学学会（ÖGGH）和奥地利介入放射学学会（ÖGIR）的共识会议上制定的。基于国际指南，并考虑到最近的里程碑式研究，比尔罗特 III 建议旨在帮助医生指导门脉高压患者的诊断和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/147d9637fca9/508_2017_1262_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/ec66094c437e/508_2017_1262_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/16925002cccc/508_2017_1262_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/27971520c200/508_2017_1262_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/147d9637fca9/508_2017_1262_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/ec66094c437e/508_2017_1262_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/16925002cccc/508_2017_1262_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/27971520c200/508_2017_1262_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ef/5674135/147d9637fca9/508_2017_1262_Fig4_HTML.jpg

相似文献

1
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).奥地利门静脉高压管理和治疗共识指南（Billroth III）。
Wien Klin Wochenschr. 2017 Nov;129(Suppl 3):135-158. doi: 10.1007/s00508-017-1262-3. Epub 2017 Oct 23.
2
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).奥地利共识：晚期慢性肝病中门静脉高压的诊断与管理（Billroth IV）。
Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26.
3
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).奥地利共识：门静脉高压及其并发症的定义和治疗（毕罗氏Ⅱ式）。
Wien Klin Wochenschr. 2013 Apr;125(7-8):200-19. doi: 10.1007/s00508-013-0337-z. Epub 2013 Apr 12.
4
Carvedilol: the β-blocker of choice for portal hypertension?卡维地洛：门静脉高压的首选β受体阻滞剂？
Gut. 2013 Nov;62(11):1529-30. doi: 10.1136/gutjnl-2012-304182. Epub 2013 Jan 26.
5
Pharmacologic prevention of variceal bleeding and rebleeding.药物预防静脉曲张出血和再出血。
Hepatol Int. 2018 Feb;12(Suppl 1):68-80. doi: 10.1007/s12072-017-9833-y. Epub 2017 Dec 5.
6
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.门静脉高压继发胃肠道出血的诊断与治疗。美国胃肠病学会实践参数委员会
Am J Gastroenterol. 1997 Jul;92(7):1081-91.
7
Prevention and treatment of variceal haemorrhage in 2017.2017 年食管胃静脉曲张出血的防治。
Liver Int. 2017 Jan;37 Suppl 1:104-115. doi: 10.1111/liv.13277.
8
[Variceal hemorrhage: primary and secondary prophylaxis].[静脉曲张出血：一级和二级预防]
Dtsch Med Wochenschr. 2004 Sep 3;129 Suppl 2:S68-70. doi: 10.1055/s-2004-831376.
9
Carvedilol versus variceal band ligation for prevention of the first variceal bleed.卡维地洛与曲张静脉套扎术预防首次静脉曲张出血的比较。
Hepatology. 2010 Feb;51(2):718-9. doi: 10.1002/hep.23336.
10
Beta-blockers to prevent esophageal varices--an unfulfilled promise.β受体阻滞剂预防食管静脉曲张——未实现的承诺。
N Engl J Med. 2005 Nov 24;353(21):2288-90. doi: 10.1056/NEJMe058208.

引用本文的文献

1
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response.经颈静脉肝内门体分流术：需要更小的支架直径来优化压力反应。
ILIVER. 2023 May 27;2(2):89-96. doi: 10.1016/j.iliver.2023.05.004. eCollection 2023 Jun.
2
Chinese guidelines on the management of ascites in cirrhosis : Chinese Society of Hepatology, Chinese Medical Association.中国肝硬化腹水规范化管理指南：中华医学会肝病学分会。
Hepatol Int. 2024 Aug;18(4):1071-1089. doi: 10.1007/s12072-024-10697-z. Epub 2024 Jul 9.
3
Validation of a Machine Learning Algorithm, EVendo, for Predicting Esophageal Varices in Hepatocellular Carcinoma.

本文引用的文献

1
Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.用于治疗肝硬化难治性腹水患者的自动低流量腹水泵
Therap Adv Gastroenterol. 2017 Feb;10(2):283-292. doi: 10.1177/1756283X16684688. Epub 2017 Jan 5.
2
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.一项随机试验评估了门静脉压力指导治疗预防静脉曲张再出血是否能改善肝硬化患者的生存率。
Hepatology. 2017 May;65(5):1693-1707. doi: 10.1002/hep.29056. Epub 2017 Mar 30.
3
Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
机器学习算法 EVendo 预测肝细胞癌食管静脉曲张的验证。
Dig Dis Sci. 2024 Aug;69(8):3079-3084. doi: 10.1007/s10620-024-08449-y. Epub 2024 Jun 19.
4
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.在一个大型的、真实世界的肝硬化患者队列中，他汀类药物、二甲双胍和肾素-血管紧张素系统（RAS）抑制剂并未降低静脉曲张出血风险和死亡率。
PLoS One. 2024 Jun 13;19(6):e0302811. doi: 10.1371/journal.pone.0302811. eCollection 2024.
5
CBCT-based three-dimensional dual-phase vascular image fusion: a novel technique for interventional real-time TIPS guidance.基于 CBCT 的三维双时相血管图像融合：介入实时 TIPS 引导的新技术。
Radiologie (Heidelb). 2024 Nov;64(Suppl 1):60-65. doi: 10.1007/s00117-024-01265-5. Epub 2024 Feb 21.
6
Transient elastography and von Willebrand factor as predictors of portal hypertension and decompensation in children.瞬时弹性成像和血管性血友病因子作为儿童门静脉高压和失代偿的预测指标
JHEP Rep. 2023 Oct 12;5(12):100935. doi: 10.1016/j.jhepr.2023.100935. eCollection 2023 Dec.
7
Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.晚期失代偿性肝硬化的表现极为常见，但成功的病因治疗可带来良好的临床结果。
PLoS One. 2023 Aug 24;18(8):e0290352. doi: 10.1371/journal.pone.0290352. eCollection 2023.
8
An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis.稳定期肝硬化患者垂体 - 肾上腺信号轴受损与预后较差有关。
JHEP Rep. 2023 May 11;5(8):100789. doi: 10.1016/j.jhepr.2023.100789. eCollection 2023 Aug.
9
Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness.基于肝脾硬度的预测高危食管静脉曲张的无创模型。
World J Gastroenterol. 2023 Jul 7;29(25):4072-4084. doi: 10.3748/wjg.v29.i25.4072.
10
Timing of endoscopy in patients with cirrhosis and acute variceal bleeding: a single-center retrospective study.肝硬化合并急性静脉曲张出血患者内镜检查时机：一项单中心回顾性研究。
BMC Gastroenterol. 2023 Jun 26;23(1):219. doi: 10.1186/s12876-023-02766-8.
球囊闭塞逆行经静脉闭塞术与经颈静脉肝内门体分流术治疗胃静脉曲张出血止血效果的比较。
J Gastroenterol Hepatol. 2017 Aug;32(8):1487-1494. doi: 10.1111/jgh.13729.
4
Acute kidney injury in liver cirrhosis: new definition and application.肝硬化中的急性肾损伤：新定义与应用
Clin Mol Hepatol. 2016 Dec;22(4):415-422. doi: 10.3350/cmh.2016.0056. Epub 2016 Dec 14.
5
New diagnostic criteria and management of acute kidney injury.急性肾损伤的新诊断标准与管理
J Hepatol. 2017 Apr;66(4):860-861. doi: 10.1016/j.jhep.2016.10.024. Epub 2016 Oct 29.
6
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease.无干扰素方案可改善晚期肝病合并 HIV/HCV 患者的门静脉高压和组织学坏死性炎症。
Aliment Pharmacol Ther. 2017 Jan;45(1):139-149. doi: 10.1111/apt.13844. Epub 2016 Nov 7.
7
Beta adrenergic blockade and decompensated cirrhosis.β肾上腺素能阻断剂与失代偿性肝硬化。
J Hepatol. 2017 Apr;66(4):849-859. doi: 10.1016/j.jhep.2016.11.001. Epub 2016 Nov 15.
8
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.肝硬化门静脉高压出血：风险分层、诊断及管理：美国肝病研究协会2016年实践指南
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
9
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.利福昔明对失代偿期肝硬化患者的血液动力学无影响：一项随机、双盲、安慰剂对照试验。
Hepatology. 2017 Feb;65(2):592-603. doi: 10.1002/hep.28898. Epub 2016 Dec 24.
10
Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.卡维地洛的血流动力学反应可长期维持，并在肝硬化患者中带来更好的临床结局：一项前瞻性研究。
J Clin Exp Hepatol. 2016 Sep;6(3):175-185. doi: 10.1016/j.jceh.2016.01.004. Epub 2016 Jan 23.